Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07882420
Starting soon Not applicable

Role of Artificial Intelligence in Breast Cancer Screening Via Mammography

NCT07882420 · tracked via the Priya Life Science France tracker
Sponsor
Centre Antoine Lacassagne
Phase
Not applicable
Started
2027-01-31
Last updated
2026-10-20

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

Transpara software

Transpara software: use of transpara software for breast cancer screening

Study summary

to evaluate the diagnostic performance of radiologists using the Transpara™ Incepto® software to interpret 2D mammograms with tomosynthesis as part of breast cancer screening

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * A woman referred for a bilateral mammogram as part of individual or organised screening, * Patient aged 18 or over, * A patient who has read the information leaflet and signed the informed consent form, * A patient with health insurance cover. Exclusion Criteria: * Patients with a history of breast cancer, * Patients with a history of breast surgery (cosmetic and/or therapeutic), * Patients with a history of radiotherapy to the breast, * Vulnerable populations and participants as defined in Articles 64 to 68 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017.

Primary outcome measure(s)

  • Sensitivity and specificity (diagnostic performance) of radiologist using the Transpara software — 2 years
    Medical conclusion of radiologist using the Transpara software at baseline compared to radiologist's decision alone at 2 years, or the result of the biopsy (positive during the follow-up period or negative at 2 years).

Trial sites (2)

FacilityCityRegionStatus
Institut Paoli Calmette Marseille France
Centre Antoine Lacassagne Nice France

More Centre Antoine Lacassagne trials in France

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) Recruiting
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer Recruiting
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment Recruiting
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Active, not recruiting
Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy Recruiting

Other trials for the same condition

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer Active, not recruiting
Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers Recruiting
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA) Starting soon
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability Recruiting
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07882420 on ClinicalTrials.gov ↗ ← All trials in France